380 related articles for article (PubMed ID: 31322047)
21. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
Tin AS; Sundar SN; Tran KQ; Park AH; Poindexter KM; Firestone GL
Anticancer Drugs; 2012 Apr; 23(4):370-9. PubMed ID: 22185819
[TBL] [Abstract][Full Text] [Related]
22. [Cell cycle alterations of human embryo lung fibroblasts induced by benzo(a)pyrene is positively regulated by cyclin D1 and CDK4].
Du H; Liu B; Tang N; Shi X
Wei Sheng Yan Jiu; 2008 Jul; 37(4):393-6. PubMed ID: 18839518
[TBL] [Abstract][Full Text] [Related]
23. Wogonin induces G1 phase arrest through inhibiting Cdk4 and cyclin D1 concomitant with an elevation in p21Cip1 in human cervical carcinoma HeLa cells.
Yang L; Zhang HW; Hu R; Yang Y; Qi Q; Lu N; Liu W; Chu YY; You QD; Guo QL
Biochem Cell Biol; 2009 Dec; 87(6):933-42. PubMed ID: 19935879
[TBL] [Abstract][Full Text] [Related]
24. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
25. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF
IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117
[TBL] [Abstract][Full Text] [Related]
26. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
[TBL] [Abstract][Full Text] [Related]
27. The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
Tanaka S; Suzuki K; Sakaguchi M
Breast Cancer; 2017 Sep; 24(5):658-666. PubMed ID: 28070831
[TBL] [Abstract][Full Text] [Related]
28. Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4.
Chen S; Guan X; Wang LL; Li B; Sang XB; Liu Y; Zhao Y
Gene; 2017 Nov; 635():3-8. PubMed ID: 28888575
[TBL] [Abstract][Full Text] [Related]
29. PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma.
Yang H; Zhao X; Zhao L; Liu L; Li J; Jia W; Liu J; Huang G
Oncotarget; 2016 Nov; 7(44):72131-72147. PubMed ID: 27708221
[TBL] [Abstract][Full Text] [Related]
30. Salidroside blocks the proliferation of pulmonary artery smooth muscle cells induced by platelet‑derived growth factor‑BB.
Chen C; Tang Y; Deng W; Huang C; Wu T
Mol Med Rep; 2014 Aug; 10(2):917-22. PubMed ID: 24840151
[TBL] [Abstract][Full Text] [Related]
31. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling.
Fan HN; Zhu MY; Peng SQ; Zhu JS; Zhang J; Qu GQ
Pathol Res Pract; 2020 Feb; 216(2):152795. PubMed ID: 31879047
[TBL] [Abstract][Full Text] [Related]
32. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.
Kennedy AL; Vallurupalli M; Chen L; Crompton B; Cowley G; Vazquez F; Weir BA; Tsherniak A; Parasuraman S; Kim S; Alexe G; Stegmaier K
Oncotarget; 2015 Oct; 6(30):30178-93. PubMed ID: 26337082
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of cdk4/cyclin D1 induces apoptosis in PC12 cells in the presence of trophic support.
Katayama K; Dobashi Y; Kitagawa M; Kamekura S; Kawai M; Kadoya Y; Kameya T
FEBS Lett; 2001 Dec; 509(3):382-8. PubMed ID: 11749960
[TBL] [Abstract][Full Text] [Related]
34. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation.
Cheng YH; Li LA; Lin P; Cheng LC; Hung CH; Chang NW; Lin C
Toxicol Appl Pharmacol; 2012 Sep; 263(3):360-7. PubMed ID: 22820424
[TBL] [Abstract][Full Text] [Related]
35. Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients.
Vlenterie M; Hillebrandt-Roeffen MH; Schaars EW; Flucke UE; Fleuren ED; Navis AC; Leenders WP; Versleijen-Jonkers YM; van der Graaf WT
Ann Surg Oncol; 2016 Sep; 23(9):2745-52. PubMed ID: 27334220
[TBL] [Abstract][Full Text] [Related]
36. The inhibitory mechanism by curcumin on the Zac1-enhanced cyclin D1 expression in human keratinocytes.
Hung CT; Huang SM; Cheng HC; Liu ST; Chang YL; Liu YC; Wang WM
J Dermatol Sci; 2015 Sep; 79(3):262-7. PubMed ID: 26094054
[TBL] [Abstract][Full Text] [Related]
37. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1, cancer progression, and opportunities in cancer treatment.
Qie S; Diehl JA
J Mol Med (Berl); 2016 Dec; 94(12):1313-1326. PubMed ID: 27695879
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Masamha CP; Benbrook DM
Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
[TBL] [Abstract][Full Text] [Related]
40. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
